Induced pluripotent stem cells (iPSCs) hold great promise for autologous cell therapies, but
significant roadblocks remain to translating iPSCs to the bedside. For example, concerns …

The ability to reprogram somatic cells into induced pluripotent stem cells (iPSCs) using
defined factors provides new tools for biomedical research. However, some iPSC clones …

Induced pluripotent stem cells (iPSCs) can be derived from many mouse and human
somatic cell types by forced expression of a small number of defined reprogramming factors …

Differentiated cells can be reprogrammed into pluripotent stem cells, known as “induced
pluripotent stem cells”(iPSCs), through the overexpression of defined transcription factors …

The recent generation of induced pluripotent stem cells (iPSCs) from somatic cells provides
an invaluable resource for drug or toxicology screening, medical research, and patient …

Induced pluripotent stem cells (iPSCs) are defined as reprogrammed somatic cells
exhibiting embryonic stem cell characteristics. Since their discovery in 2006, efforts have …

Donor-specific induced pluripotent stem cells (iPSCs) offer opportunities for personalized
cell replacement therapeutic approaches due to their unlimited self-renewal potential and …

Tissues derived from induced pluripotent stem cells (iPSCs) are a promising source of cells
for building various regenerative medicine therapies; from simply transplanting cells to …

Induced pluripotent stem cells (iPSCs) derived from reprogrammed somatic cells are
emerging as one of the most versatile tools in biomedical research and pharmacological …

The induced pluripotent stem cells (iPSCs), derived by ectopic expression of reprogramming
factors in somatic cells, can potentially provide unlimited autologous cells for regenerative …